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Abstract
The lack of reliable methods to efficiently isolate and propagate stem cell populations is a significant obstacle to the
advancement of cell-based therapies for human diseases. One isolation technique is based on efflux of the fluorophore
Hoechst 33342. Using fluorescence-activated cell sorting (FACS), a sub-population containing adult stem cells has been
identified in a multitude of tissues in every mammalian species examined. These rare cells are referred to as the ‘side
population’ or SP due to a distinctive FACS profile that results from weak staining by Hoechst dye. Although the SP contains
multi-potent cells capable of differentiating toward hematopoietic and mesenchymal lineages; there is currently no method
to efficiently expand them. Here, we describe a spinner-flask culture system containing C2C12 myoblasts attached to
spherical microcarriers that act to support the growth of non-adherent, post-natal murine skeletal muscle and bone marrow
SP cells. Using FACS and hemocytometry, we show expansion of unfractionated EGFP
+ SP cells over 6 wks. A significant
number of these cells retain characteristics of freshly-isolated, unfractionated SP cells with respect to protein expression and
dye efflux capacity. Expansion of the SP will permit further study of these heterogeneous cells and determine their
therapeutic potential for regenerative and reparative therapies.
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Introduction
The side population (SP) is a heterogeneous cell fraction that
contains tissue-specific stem cells, which can be isolated from
a multitude of tissues [1,2,3,4,5]. SP cells are also present as a sub-
population in embryonic stem (ES) cell cultures, human solid
tumors, and immortalized cell lines [6]. This fraction is identified
by efflux of cell-permeant fluorescent dyes; an attribute that
produces a characteristic profile upon analysis by cytometry [7,8].
The ability to expel dyes from the cytoplasm results from
expression of ATP-binding cassette proteins such as ABCG2 (also
known as breast cancer resistance protein 1 [Bcrp1]) [9]. These
proteins belong to a family of membrane-bound, multi-drug
resistance transporters that discharge substrates into the extracel-
lular space against steep concentration gradients in an energy
dependent manner. The ability of SP cells to eliminate xenobiotic
substances such as Hoechst 33342 and Rhodamine 123 as well as
chemotherapeutic agents is believed to ensure their survival and
likely accounts for their persistence in normal organs as well as in
cancerous tissues and cell lines.
Since the discovery of SP cells, this population has been
intensively investigated as a candidate for a multitude of
regenerative and reparative therapies [5,10,11]. Despite this, it is
apparent there are important problems to address before any
therapy could become a clinical reality. In particular, the low rates
of cell engraftment to target tissues, the inherent heterogeneity of
the SP fraction, and a failure to expand these cells to a scale
commensurate with a therapeutic application in humans continue
to represent significant challenges. Establishing a reliable means to
culture undifferentiated SP cells will permit comprehensive
experimental evaluation and, ultimately, assessment of their
therapeutic potential for a number of clinical applications.
To date, there have been few attempts to grow primary SP cells.
In general, SP cells appear as non-adherent, small, circular cells
with little proliferative capability. They are also predisposed to
differentiate into multiple lineages upon attachment to a substrate
[12]. If the SP fraction is derived from oncogenic cell lines or
tumor cells, expansion in culture is feasible; though, the clinical
utility of these cells is questionable as is their differentiation
potential. Most experiments with cultured SP cells have been
performed using viscous or semi-solid matrices to ascertain their
hematopoietic potential [3]. These conditions promote differenti-
ation and proliferation of hematopoietic cells allowing the progeny
of single cells to form colonies of mature cells. While these cultures
are optimized for outgrowth of hematopoietic colonies, they are of
little utility for expansion of SP cells for regenerating or repairing
solid tissues.
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murine SP cells isolated from post-natal skeletal muscle and bone
marrow. Non-adherent SP cells were expanded in suspension
using paddle-impeller stirred flasks containing C2C12 myoblasts
that were intended to function as support or ‘feeder’ cells,
analogous to methods established to propagate ES cells [13]. At
the same time, SP and C2C12 cells had different substrate
attachment requirements; so, we seeded feeder cells on spherical
microcarriers. With this approach, myoblasts were grown as
monolayers on the surface of microcarriers and free-floating SP
cells were added to suspension cultures [14]. The C2C12 line was
chosen as a feeder cell to superficially resemble a muscle stem cell
niche because we are primarily interested in developing cell-based
therapies for skeletal muscle diseases. Here, we show expanded
cells can be divided into two populations; one that closely
resembles freshly-isolated SP cells and another that includes cells
that are likely undergoing lineage commitment and differentiation.
Materials and Methods
Ethics Statement
Animal procedures were approved by the Institutional Animal
Care and Use Committee at Boston Children’s Hospital (animal
welfare assurance N
o. A3303-01) and conducted according to the
‘Guide for the Care and Use of Laboratory Animals’ by the
National Research Council.
Isolation of SP Cells
Pooled skeletal muscle and whole bone marrow from femurs
were collected and processed from 3 to 5 wk old male (=) C57BL/
6-Tg [ACTB-EGFP] 1Osb/J mice (Jackson Laboratories) [10].
For isolation of SP cells using flow cytometry, dissociated cells were
filtered through a 40 mm cell strainer (Falcon), centrifuged (600 g)
at 4uC for 10 min, and resuspended (10
6 cells/mL) in phosphate
buffered saline (PBS) containing 0.5% fraction V bovine serum
albumin (BSA).
Hoechst 33342 (Sigma) was added at 5 mg/mL for bone
marrow cells and 12.5 mg/mL for skeletal muscle cells [7,8,10]. In
parallel, as a negative control for SP cell gating, 1610
6 cells were
stained in the presence of 100 mM verapamil (Sigma). Staining
took place for 90 min at 37uC and cells were washed with 5
volumes of 16phosphate buffered saline-0.5% bovine serum
albumin (PBS-BSA). Prior to cytometric analyses, cells were
resuspended in PBS-0.5% BSA containing 2 mg/mL propidium
iodide (PI) (Sigma) for 5 min. Cell sorting and analyses were
performed using a FACSVantage SE system (BD Biosciences)
using both a 488 nm argon ion laser at 200 mW (Coherent,
Innova C) and a multi-line high UV 365 nm laser at 150 mW
(Coherent, Innova 90-6) [7]. Hoechst and PI were both excited at
365 nm and emission signals were separated with a 500 short-pass
dichroic mirror. Fluorescence emission was measured using 400
and 600 nm long-pass filters for Hoechst and PI, respectively.
Enhanced green fluorescent protein (EGFP) was excited at 488 nm
and emission signals passed through the same dichroic mirror and
subsequently detected using a 530/30 band-pass filter. The sort
head frequency was ,26,000 Hz using the ‘normal sort’ mode
and the sheath pressure was 11–12 psi. Using the conditions
described by Montanaro et al. [7], cell viability, homogeneity, and
yield was optimal for SP cells isolated from these tissues. A
minimum of 20,000 live cell counts was acquired using CellQuest
software (BD Biosciences) and then analyzed with FlowJo (Tree
Star).
SP Cell Expansion in Suspension Culture
Female (R) C2C12 myoblasts (ATCC) were expanded on
150 mm plates (BD Biosciences) in high-glucose DMEM Gluta-
MAX with pyruvate (Life Technologies) containing 20% fetal
bovine serum (FBS) (Atlanta Biologicals), 1% penicillin-strepto-
mycin (Invitrogen), and 1% Fungizone (Invitrogen) prior to rinsing
with PBS and detachment with 0.05% trypsin-EDTA (Life
Technologies). Cells were collected by centrifugation at (600 g),
resuspended in media and mixed with hydrated and sterilized
Cytodex 1 microcarriers (Amersham Biosciences) on bacteriolog-
ical Petri dishes (BD Biosciences). 1610
6 microcarriers were
distributed to form a single layer and the use of Petri dishes
promoted attachment to the Cytodex 1. Dishes were placed in
a humidified culture incubator (Sanyo) with 5% CO2 and agitated
every 15 min for 2 hr. C2C12 cells were seeded at a concentration
of 50–100 cells per microcarrier. The cell-coated microcarriers
were then divided into 2 Sigmacote (Sigma)-treated and sterilized
100 mL borosilicate glass spinner-flasks. Each flask contained two
angled side-arms and an internal overhead-bearing impeller with
a polytetrafluoroethylene paddle (Bellco Glass). Flasks were filled
to 100 mL with media and the side-arm caps were loosened to
allow for gas transfer. The flask contents were stirred at 30 rpm
using a 5-position magnetic stirrer (Bellco Glass).
After 48–72 hr, the media was supplemented with 5 ng/L basic
fibroblast growth factor (bFGF) (Life Technologies) and each flask
was inoculated with freshly-isolated SP cells from skeletal muscle
or bone marrow. Media in the flasks was replenished every 2–3
days by allowing the microcarriers and SP cells to settle for 10 min
and then removing 50–70% of the media from the top of the flask
and replacing it with freshly-prepared media containing 5 ng/L
bFGF. Aliquots (5 mL) were collected from the side-arms at 3, 7,
10, 14, and 15 days for enumeration by hemocytometry and
analysis by flow cytometry. Cultures were passaged 15 days after
SP cell inoculation by collecting the contents of the flasks by
gravity and dispersing the PBS-rinsed cell and microcarrier
aggregates with 1% trypsin (Worthington) and agitation using
a3 7 uC Enviro-genie incubator (Scientific Industries). Microcar-
riers were removed by passing the mixture through a 100 mM cell
strainer (Falcon) and cells were collected by centrifugation and
resuspended in media containing bFGF. These cells were added to
prepared 250 mL spinner-flasks each containing 1610
6 micro-
carriers and cultured as described above. Cultures were main-
tained for 2 additional passages (i.e. P0 in a 100 mL flask, P1 in
a 250 mL flask, and P2 in two 250 mL flasks, for each culture).
Phenotyping and Growth Measurements
Throughout SP expansion, trypsinized aliquots were assessed
for cell number and EGFP expression by a hemocytometer imaged
with bright field and fluorescence illumination. Phenotypic
characterization of cells was conducted by determining surface
marker expression using flow cytometry [7]. Cultured cells were
also assayed for intrinsic fluorescence and efflux of Hoechst using
flow cytometry. Rat anti-mouse phycoerythrin (PE)-conjugated
antibodies raised against CD45 (clone 30-F11), Sca-1 (clone E13-
161.7), and IgG2a,k control antibodies (clone R35-95) (BD
Biosciences) were used as described previously [7,10]. Cells were
washed with PBS-0.5% BSA, centrifuged, and resuspended in
PBS-0.5% BSA and then analyzed as described earlier [7,10]. For
analysis of cells stained with fluorescently-conjugated primary
antibodies using the FACSVantage SE system (BD Biosciences),
EGFP and PE were excited with the 488-nm laser and emission
signals were detected using either 530/30 or 575/25 band-pass
filters [7]. Samples labeled with isotype-specific control antibodies
A Suspension Co-Culture System for SP Stem Cells
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compensate for optimal separation of fluorescence.
Staining of SP Cells
Aliquots from expansion cultures were fixed with 4% para-
formaldehyde (PFA) in PBS for 1 hr at 4uC and, if detecting
intracellular proteins, permeabilized for 3 min with 0.1% Triton
X-100 in PBS. Microcarrier cultures or Shandon Cytospin
(Thermo Scientific)-prepared slides of EGFP-positive (EGFP
+)
cells (3000 cells per slide) were used for immuno-staining. Primary
antibodies were used at 1–10 mg/mL and incubated at 22uC for
30 min. In parallel, each preparation was incubated with
a negative control antibody (Dako). The primary antibodies used
include desmin (Sigma), myogenin (Dako), a-sarcomeric actin
(Sigma), Pax7 (Developmental Studies Hybridoma Bank), MyoD
(RDI), ABCG2 (Chemicon), a-actinin 2 [15] and Sca-1 (BD
Biosciences). For detection of antibodies not fluorescently-conju-
gated, species-appropriate Alexa-conjugated secondary antibodies
(Life Technologies) were used and mixed with 49, 6-diamidino-2-
phenylindole dihydrochloride (DAPI) (Life Technologies). In some
cases, Texas Red-X phalloidin (Life Technologies) was used to
stain the actin cytoskeleton (i.e. filamentous [F]-actin). Cells were
visualized on a CARV spinning-disk confocal system (Atto
Bioscience) attached to an Axiovert 200M microscope (Carl
Zeiss). Images were acquired with a CoolSNAP HQ camera
(Photometrics) controlled with MetaMorph 6.2 software (Universal
Imaging). For scanning electron microscopy (SEM), microcarrier
cultures were washed in PBS and fixed in 2.5% grade I
glutaraldehyde suspended in 0.1 M cacodylate buffer. Sample
preparation and SEM imaging was performed by Dennis Kunkel
Microscopy, Inc. (Kailua, HI).
Data Analysis
Statistical analyses were performed using InStat software
(GraphPad). Data is presented as mean (standard deviation
[SD]) and significance was determined by Student’s t test.
Results and Discussion
In this report, we describe a stirred-flask suspension culture
system adapted to expand unfractionated SP stem cells isolated
from adult skeletal muscle and bone marrow. To expedite
development of the expansion system, we used murine cells in
order to isolate fluorescent SP cells from = C57BL/6-Tg [ACTB-
EGFP] 1Osb/J mice and co-culture these with unlabeled R C2C12
cells. Our previous attempts to culture SP cells in suspension
without the presence of supporting feeder cells resulted in no
proliferation of this population; however, another group has
reported the co-culture of murine skeletal muscle SP cells with
primary myoblasts, C2C12 myoblasts, and C3H10T1/2 fibro-
blasts [2]. Although their goal was to examine the differentiation
potential of SP cells rather than to expand this population,
Asakura et al. demonstrated myogenic specification of SP cells in
the presence of primary or C2C12 myoblasts, but not with the
fibroblast cell line or when cultured alone using conditioned
medium from primary myoblast cultures [2]. Because we are
interested in developing cell-based therapies for skeletal muscle
diseases, we used this information to help design our expansion
system.
Rather than simply mixing cells together in a conventional
culture plate, we reasoned a 3-dimensional bioreactor would
produce better cell yields and allow for isolation of the SP from co-
cultures for subsequent directed differentiation and transplantation
studies. Consequently, adherent, non-fluorescent R C2C12 cells
were seeded onto Cytodex 1 microcarriers to function as a feeder
cell layer. This culture strategy permited determination of the
disposition of the = EGFP
+ SP cells by intrinsic fluorescence,
antibody reactivity, or if necessary, Y chromosome staining using
fluorescence in situ hybridization. We found skeletal muscle and
bone marrow SP expansion through each of 3 passages and
a proportion of the EGFP
+ cells retained attributes of freshly-
isolated SP stem cells with respect to surface markers, protein
expression, and Hoechst dye efflux. The ability to generate large
numbers of SP cells will allow for further experimental character-
ization and, ultimately, determine the regenerative and reparative
potential of these adult tissue-specific stem cells.
We began our studies by isolating SP cells from bone marrow
(Fig. 1A) and skeletal muscle (Fig. 1B) [7,8]. Using established
Hoechst concentrations, we observed a typical SP profile when
cytometry data was presented as a two-dimensional plot for each
tissue. The SP fraction was reduced by addition of the calcium
channel blocker verapamil due to inhibition of ATP-binding
cassette transporter activity [7,8]. Examination of SP cells revealed
small fluorescent cells that appeared indistinguishable regardless of
their tissue source (Fig. 1C). Because we are interested in
developing therapies for muscle diseases, to standardize and
simplify development of the expansion system, we chose to co-
culture SP cells with non-fluorescent C2C12 myoblasts (Fig. 1D).
Cells isolated from bone marrow or skeletal muscle of ACTB-
EGFP mice were confirmed to be fluorescent regardless of whether
they comprised the SP or ‘main population’ (MP) (Fig. 1E). These
results demonstrate proficient isolation of EGFP
+ SP cells from
murine bone marrow or skeletal muscle and further shows the
latter cells are easily distinguished from non-fluorescent C2C12
myoblasts. This distinction served as a starting point for
development of an co-culture expansion system (Fig. 2).
The workflow for initiating this system is depicted in Fig. 2A.
Briefly, C2C12 cells were expanded in standard culture plates and
then seeded on Cytodex 1 microcarriers, which are composed of
cross-linked dextran in a spherical matrix. After static seeding to
allow cells to adhere to the microcarrier surface, cultures were
maintained at 30 rpm in spinner-flasks. Each 100 mL flask
contained 500,000 Cytodex 1 microcarriers and most spheres
had about 100 cells on their surface (i.e. 5610
7 C2C12 cells/
100 mL stirred-flask). By the time bFGF was added to the media
to support SP cell expansion, the microcarriers were completely
covered and the myoblasts had begun to spread and fuse with one
another. Immuno-staining showed extensive coverage of the
Cytodex surface with cells expressing a-sarcomeric actin and F-
actin (Figs. 2B and 2C). Skeletal muscle and bone marrow EGFP
+
SP cells were added to flasks and cultures were intermittently
assessed for propagation. We found DMEM with 20% FBS plus
5 ng/mL bFGF brought about a dramatic rise in the number of
EGFP
+ cells after 2 wks (Fig. 2D).
One issue that became apparent during the course of these
experiments was the loss of feeder cells from the microcarrier
surface in cultures maintained for greater than 15 days (Fig. 2D).
This phenomenon was likely due to prolonged exposure to shear
stress and resulted in a decline in EGFP
+ cell expansion. To avoid
this problem, we passaged cells every 2 wks. In this way, single
100 mL stirrer flasks for bone marrow or skeletal muscle SP cell
expansion (P0) were transferred to 250 mL flasks (P1) containing
freshly-seeded microcarriers. P1 cultures were then used to
inoculate a pair of 250 mL flasks (P2). While this process allowed
for expansion of the EGFP
+ fraction, we found that cell
proliferation was not completely scalable as passaging to
a 1000 mL stirrer flask caused a collapse in the EGFP
+ cell
population. This probably resulted from inadequate gas transfer
A Suspension Co-Culture System for SP Stem Cells
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rather than relying on passive diffusion. We were also anticipating
that non-adherent SP cells could be effortlessly separated from
feeder cells attached to the microcarriers by allowing the Cytodex
spheres to sink to the bottom of the flasks or filtering them out with
a cell strainer and collecting free-floating cells. We did not observe
segregation of non-fluorescent cells from EGFP
+ cells. Over time,
fluorescent cells were attached to or clustered around the
microcarriers; so, separation of expanded cells required a cell
sorter.
To define the growth of EGFP
+ cells in suspension, we obtained
aliquots of cells at different times following the initial inoculation of
SP cells. Expanded cells were enumerated by hemocytometry and
characterized for Hoechst dye efflux and EGFP fluorescence by
FACS (Fig. 3). Cytometric analyses were performed in 4
independent cultures for 3 passages (P0, P1, and P2). Typical
FACS plots for P2 bone marrow (Fig. 3A) and skeletal muscle
(Fig. 3B) cultures show increases in EGFP
+ cells over time.
Intriguingly, many of these cells eliminated Hoechst dye compa-
rable to freshly-isolated SP cells, whereas other cells sorted to the
MP position. In other words, for a typical assay of skeletal muscle
from a single mouse, we acquired 14,885.5 (7,885.7) (Mean [SD])
viable skeletal muscle SP cells and 41,874.3 (21,642.2) (Mean
[SD]) bone marrow SP cells from a single EGFP-expressing
mouse. The significant rise in EGFP
+ cells in P0 cultures is
depicted in Fig. 3C, which clearly shows better expansion of bone
marrow cultures compared to skeletal muscle cultures. In bone
marrow SP expansion cultures, the number of EGFP
+ cells
increased from approximately 4.2610
4 to 8.1610
6 (Fig. 3C) in the
P0 cultures, which represents an estimated doubling time of 1.8
days. In comparison, skeletal muscle EGFP
+ expansion cultures
had a doubling time of 2.3 days. Similar growth rates were
observed in P1 and P2 suspension cultures inoculated with
comparable numbers of EGFP
+ cells as P0 cultures (Fig. 3D).
Together these results point toward a continuous and reproducible
expansion of SP-derived EGFP
+ cells over a period of 6 wks.
Additional FACS analyses of the expansion cultures established
the EGFP
+ fraction exhibited variable green fluorescence emission
that could be exploited to isolate highly-purified SP cells by
excluding cells that underwent a decrease in Hoechst efflux (Fig. 4).
We observed EGFP
+ cells could be distinguished as intensely or
weakly fluorescent in both bone marrow (not shown) and skeletal
muscle cultures (Fig. 4A). Highly-fluorescent EGFP
+ cells, which
we termed the EGFP
high population, displayed a nearly identical
Hoechst 33342 FACS profile as freshly-isolated SP cells. In
contrast, weakly fluorescent EGFP
+ cells (termed the EGFP
low
fraction) showed a similar distribution of Hoechst/PI-stained cells
as expanded cells did when determined en masse. As a result, we
identified a means to distinguish expanded SP cells from mixed
populations of EGFP
+ SP and SP-derived cells.
Figure 1. Isolation of SP cells from murine bone marrow and
skeletal muscle. A – Representative FACS plots of bone marrow cells
stained with Hoechst 33342 and PI. All plots show 20,000 events.
Addition of verapamil eliminated the SP. The linear X and Y axes show
PI and Hoechst staining, respectively. B – Representative FACS plots of
skeletal muscle cells stained with Hoechst 33342 and PI (20,000 events
per plot) in the absence (left) or presence (right) of verapamil. C – The
appearance of bone marrow (left) and skeletal muscle (right) SP cells
under combined bright field and fluorescence illumination. EGFP-
expressing SP cells are shown on a hemocytometer grid and scale bars
represent 50 mm (left) and 10 mm (right). D – Representative intrinsic
fluorescence in C2C12 cells and unfractionated bone marrow from
EGFP-expressing mice. The X axis depicts forward scatter (FSC-H) using
a linear scale and the Y axis shows fluorescence using a logarithmic
scale. E – Representative fluorescence in MP and SP fractions in
enzymatically-digested skeletal muscle from ACTB-EGFP transgenic
mice.
doi:10.1371/journal.pone.0055187.g001
A Suspension Co-Culture System for SP Stem Cells
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high and EGFP
low fractions repre-
sented the SP and a mixed population of SP as well as ‘SP-derived’
MP cells, respectively, was achieved by antibody staining and
analysis by flow cytometry and fluorescence microscopy. The
tyrosine phosphatase CD45 is located on many hematopoietic cells
and is often used as a marker for bone marrow, whereas Sca-1 (Ly-
Figure 2. Appearance of microcarrier-based cultures from stirred-flasks. A – A schematic representation of the initial steps in establishing
a SP expansion culture. R C2C12 myoblasts are expanded and seeded on 500,000 Cytodex 1 microcarriers (left). After attachment to the microcarrier
surface, cultures are transferred to 100 mL flasks and maintained for 2–3 days. Freshly-isolated bone marrow (BM) or skeletal muscle (SkM) SP cells
isolated from = EGFP-expressing mice are added and stirred at 30 rpm. B – Fluorescent staining of C2C12-containing Cytodex 1 microcarriers using
DAPI (blue), an a-sarcomeric actin antibody detected with a conjugated secondary antibody (green), and Texas Red-X phalloidin (red). The combined
image is on the right and the scale bar represents 100 mm. C – A closer view of a cellularized microcarrier stained for F-actin and DNA (left) as well as 2
scanning electron micrographs (SEMs). The SEMs were pseudo-colored to emphasize the dextran matrix on the microcarrier surface. Scale bars equal
100 mm (left and center) and 50 mm (right). D – Differential interference contrast, fluorescence, and combined images of day 18 co-cultures of SP cells
from bone marrow and myoblast feeder cells. Scale bar equals 100 mm.
doi:10.1371/journal.pone.0055187.g002
A Suspension Co-Culture System for SP Stem Cells
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populations. Cytometric analyses of these markers along with
EGFP fluorescence is shown in Fig. 4B. Similar to what is observed
in freshly-isolated SP cells, bone marrow EGFP
+ cells were positive
for CD45 while none of the skeletal muscle EGFP
+ cells expressed
this marker [1,7,16]. On the other hand, Sca-1 was positive in
22.4% (4.8) (Mean [SD], n=3) of bone marrow EGFP
+ cells and
30.1% (9.2) (Mean [SD], n=3) of skeletal muscle EGFP
+ cells.
These findings vary to some extent from earlier reports indicating
variation in Sca-1 expression that may be the consequence of
in vitro expansion [2,17].
Previous studies have established freshly-isolated muscle SP cells
are negative for CD45, CD43, c-kit, CD11, Gr-1, B220, CD4 and
CD8, while they remain positive for Sca-1, as do some MP cells
[10]. Freshly-isolated bone marrow SP cells are typically positive
for CD45, c-kit, and Sca-1 and negative for lineage markers. In
addition, SP cells isolated from either source are negative for
myogenic markers such as Pax7, Myf5, desmin, and MyoD [2,18]
as expression of these proteins is indicative of myogenic
specification and differentiation. At present, Hoechst 33342
staining remains the standard means to distinguish the SP from
non-SP cells. While the ABCG2 transporter is expressed by bone
marrow and skeletal muscle SP cells, it is also present in many
other cell types, thereby excluding it as a unique selection marker
[19]. In addition, other ABC transporters can contribute to
Hoechst efflux and expression of these proteins is likely regulated
in a tissue- and developmental-specific manner [5]. Because our
expansion cultures utilized myoblast feeder cells, we focused on
Figure 3. Expansion of bone marrow and skeletal muscle SP cells in suspension. A – Representative FACS plots of P2 bone marrow
suspension culture analyses for EGFP-fluorescence at days 3, 10, and 15 (left). Plots show 20,000 events. Day 15 cells were assessed for Hoechst dye
effusion (right). Plots show 50,000 events. B – FACS plots of P2 skeletal muscle culture analyses for EGFP-fluorescence at days 3, 10, and 15 (left). Day
15 cells were assessed for Hoechst dye effusion (right). Both bone marrow and skeletal muscle expansion cultures demonstrated an increase in EGFP
+
cells over time and many cells were Hoechst
low, analogous to freshly-isolated SP cells. C – Expansion of EGFP
+ cells in P0 stirred-flask cultures as
determined by hemocytometry. Numerical values for the total number of EGFP
+ cells are expressed as Mean 6 SD (n=4) and asterisks represent
statistical significance (* P,0.05 and ** P,0.01) compared to day 3 values. D – Expansion of bone marrow (left) and skeletal muscle (right) EGFP
+ cells
over the course of 3 passages (P0, P1, and P2). The percentage of EGFP
+ cells in the suspension cultures is expressed as Mean 6 SD (n=4) and
asterisks represent statistical significance (* P,0.05 and ** P,0.01) compared to day 3 values.
doi:10.1371/journal.pone.0055187.g003
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cultures. The increase in the typical SP gate position in day 15 cultures is shown (left). The plot shows 50,000 events. By day 10, the appearance of
a highly-fluorescent (EGFP
high) sub-population was apparent in EGFP
+ cells and these were found to sort nearly exclusively to the SP gate (right). The
EGFP
low cells were distributed in typical SP and MP positions. B – Representative FACS analyses of surface marker expression in P2 bone marrow and
P3 skeletal muscle cultures. Plots show 20,000 events. CD45 (left) and Sca-1 (right) profiles plotted against GFP fluorescence are shown for
unfractionated aliquots of the suspension cultures. C – Representative immuno-staining results from Cytospin preparations for the EGFP
high (top) and
EGFP
low (bottom) sub-populations from skeletal muscle. The EGFP
high images show separate channels depicting DNA staining, GFP fluorescence,
ABCG2 immuno-staining, and a combination of fluorescent channels (left to right). EGFP
low images represent the same channels except the red
channel shows immuno-staining with MyoD, Pax7, desmin, and ABCG2 (left to right). Scale bars equal 25 mm. D – A summary of immuno-staining
A Suspension Co-Culture System for SP Stem Cells
PLOS ONE | www.plosone.org 7 January 2013 | Volume 8 | Issue 1 | e55187studying the expression of established markers of muscle differen-
tiation in both EGFP
high and EGFP
low fractions.
For immuno-staining experiments, we used antibodies directed
against the ABCG2 transporter, the muscle-specific intermediate
filament protein desmin, the satellite cell marker Pax7, the
myogenic regulatory proteins MyoD and myogenin, as well as
the Sca-1 antigen (Fig. 4C and 4D). EGFP
high fractions stained
nearly exclusively for the ABCG2 transporter; whereas, EGFP
low
cells stained similar to a mixed population of SP and MP cells.
Specifically, skeletal muscle EGFP
low cells were positive for the
muscle-specific marker desmin, whereas the same fraction from
expanded bone marrow SP cells was, for the most part, not
myogenic despite being cultured in the presence of myoblast
feeders. Staining for the transiently-expressed transcription factors
MyoD and myogenin indicated EGFP
low skeletal muscle cells were
undergoing myogenic specification and differentiation. There were
also a substantial number of cells from the EGFP
low fractions that
stained for ABCG2, although they generally stained less intensely
than EGFP
high cells. Obviously, some EGFP
low cells representing
the SP fraction as well as some MP cells strongly-express ABCG2
[19,20]. Together, our findings, in agreement with earlier studies,
point to a gradual loss in ABCG2 as SP cells commit to a myogenic
lineage [9]. These experiments provided evidence that the
EGFP
high fraction was equivalent to the SP and increases
throughout time in culture. This was true both within and
between individual passages (Fig. 4E).
Since we have identified a method to reliably expand SP cells
from bone marrow and skeletal muscle, an immediate goal will be
to identify novel markers for isolating and purifying these cells
without the need for fluorophores such as EGFP, Rhodamine 123,
and Hoechst 33342. Ideally, these experiments will eliminate the
need for flow cytometry to isolate expanded SP cells. This would
also avoid exposing cells to potentially mutagenic substances, high-
intensity UV light, and abolish a potential source of contamina-
tion. A second goal would be to replace C2C12 cells with MP cells
as feeders. In the end, we anticipate that subsequent studies will
determine the utility of fractionated SP cells as candidates for
tissue regeneration and repair. The means to dependably expand
the SP should foster additional experiments aimed to more fully
ascertain the therapeutic potential of these cells.
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